Erythrocyte aggregation and neutrophil function in an aging population

Gerontology

Volumn 56, Issue 2, 2010, Pages 175-180

  Christy, R M ^a   Baskurt, O K ^b   Gass, G C ^a   Gray, A B ^a   Marshall Gradisnik, S M ^a  

^a BOND UNIVERSITY   (Australia)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Erythrocyte aggregation; Fibrinogen; Phagocytic activity

Indexed keywords

ADULT; AGING; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADULT; AGING; ERYTHROCYTE AGGREGATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; YOUNG ADULT;

EID: 77949570779     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000242461     Document Type: Article

References (40)

1. McMurdo MET: A healthy old age: realistic or futile goal? BMJ 2000; 321: 1149-1151.
2. Australian Bureau of Statistics: Population by Age and Sex, Australian States and Territories. ABS, 2008.
3. Thom T, Haase N, Rosamond W, et al: Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-e151.
4. Messinger-Rapport BJ, Sprecher D: Prevention of cardiovascular diseases. Coronary artery disease, congestive heart failure, and stroke. Clin Geriatr Med 2002; 18: 463-483, vii.
5. Gardner ID: The effect of aging on susceptibility to infection. Rev Infect Dis 1980; 2: 801-810.
6. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ: Aging and innate immune cells. J Leukoc Biol 2004; 76: 291-299.
7. Wenisch C, Patruta S, Daxbock F, Krause R, Horl W: Effect of age on human neutrophil function. J Leukoc Biol 2000; 67: 40-45.
8. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M: Neutrophil ageing and immunesenescence. Mech Ageing Dev 2001; 122: 1521-1535.
9. Butcher SK, Chahal H, Nayak L, Sinclair A, Henriquez NV, Sapey E, O'Mahony D, Lord JM: Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 2001; 70: 881-886.
10. Chatta GS, Andrews RG, Rodger E, Schrag M, Hammond WP, Dale DC: Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL- 3. J Gerontol 1993; 48:M207-M212.
11. Born J, Uthgenannt D, Dodt C, Nunninghoff D, Ringvolt E, Wagner T, Fehm HL: Cytokine production and lymphocyte subpopulations in aged humans: an assessment during nocturnal sleep. Mech Ageing Dev 1995; 84: 113-126.
12. Meyer KC: Aging. Proc Am Thorac Soc 2005; 2: 433-439.
13. Feher G, Koltai K, Kesmarky G, Szapary L, Juricskay I, Toth K: Hemorheological parameters and aging. Clin Hemorheol Microcirc 2006; 35: 89-98.
14. Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD: Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1999; 104: 246-257.
15. Ajmani RS, Rifkind JM: Hemorheological changes during human aging. Gerontology 1998; 44: 111-120.
16. Lominadze D, Dean WL: Involvement of fibrinogen specific binding in erythrocyte aggregation. FEBS Lett 2002; 517: 41-44.
17. Rotstein R, Landau T, Twig A, Rubinstein A, Koffler M, Justo D, Constantiner D, Zeltser D, Shapira I, Mardi T, Goldin Y, Berliner S: The erythrocyte adhesiveness/aggregation test (EAAT): a new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors. Atherosclerosis 2002; 165: 343-351.
18. Demiroglu H: The importance of erythrocyte aggregation in blood rheology: considerations on the pathophysiology of thrombotic disorders (letter). Blood 1997; 89: 4236.
19. Baskurt OK, Farley RA, Meiselman HJ: Erythrocyte aggregation tendency and cellular properties in horse, human, and rat: a comparative study. Am J Physiol 1997; 273: H2604-H2612.
20. Zhao H, Wang X, Stoltz JF: Comparison of three optical methods to study erythrocyte aggregation. Clin Hemorheol Microcirc 1999; 21: 297-302.
21. Hardeman MR, Goedhart PT, Shin S: Methods in Hemorheology: Handbook Hemorheology and Hemodynamics. Amsterdam, IOS Press, 2007, pp 242-266.
22. Rothe G, Oser A, Valet G: Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 1988; 75: 354-355.
23. Orpegen Pharma: PhagoTEST Kit Instruction Manual. Heidelberg, Orpegen Pharma, 1996.
24. CLAUSS A: Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-246.
25. Hammi H, Perrotin P, Guillet R, Boynard M: Determination of red blood cell aggregation in young and elderly subjects evaluated by ultrasound. Clin Hemorheol 1994; 14: 117-126.
26. Lominadze D, Dean WL: Involvement of fibrinogen specific binding in erythrocyte aggregation. FEBS Lett 2002; 517: 41-44.
27. Chien S, Jan K: Ultrastructural basis of the mechanism of rouleaux formation. Microvasc Res 1973; 5: 155-166.
28. Weng X, Cloutier G, Beaulieu R, Roederer GO: Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol Heart Circ Physiol 1996; 271:H2346-H2352.
29. Kamath S, Lip GYH: Fibrinogen: biochemistry, epidemiology and determinants. QJM 2003; 96: 711-729.
30. Fu A, Nair KS: Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol Endocrinol Metab 1998; 275:E1023-E1030.
31. Rampling MW, Meiselman HJ, Neu B, Baskurt OK: Influence of cell-specific factors on red blood cell aggregation. Biorheology 2004; 41: 91-112.
32. Baskurt OK, Bor-Kucukatay M, Yalcin O, Meiselman HJ, Armstrong JK: Standard aggregating media to test the 'aggregability' of rat red blood cells. Clin Hemorheol Microcirc 2000; 22: 161-166.
33. Meiselman HJ: Red blood cell role in RBC aggregation: 1963-1993 and beyond. Clin Hemorheol 1993; 13: 575-592.
34. Lipschitz DA, Udupa KB, Boxer LA: The role of calcium in the age-related decline of neutrophil function. Blood 1988; 71: 659-665.
35. Ballou SP, Lozanski FB, Hodder S, Rzewnicki DL, Mion LC, Sipe JD, Ford AB, Kushner I: Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 1996; 25: 224-230.
36. Hager K, Felicetti M, Seefried G, Platt D: Fibrinogen and aging. Aging (Milano) 1994; 6: 133-138.
37. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC: CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci USA 1991; 88: 1044-1048.
38. Rubel C, Fernandez GC, Dran G, Bompadre MB, Isturiz MA, Palermo MS: Fibrinogen promotes neutrophil activation and delays apoptosis. J Immunol 2001; 166: 2002-2010.
39. Kindmark CO: Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin Exp Immunol 1971; 8: 941-948.
40. Berliner S, Zeltser D, Shapira I, Assayag EB, Mardi T, Serov J, Aharonov S, Arber N, Rotstein R: A simple biomarker to exclude the presence of low grade inflammation in apparently healthy individuals. J Cardiovasc Risk 2002; 9: 281-286.